Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Home functioning profiles in people with multiple sclerosis and their relation to disease characteristics and psychosocial functioning.
TREK-King the Blood-Brain-Barrier.
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.
FTY720 induces apoptosis of m2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
The role of transcriptional control in multiple system atrophy.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells.
Industry Update: The latest developments in therapeutic delivery.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.
How to run a multiple sclerosis relapse clinic.
Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.
Pages
« first
‹ previous
…
413
414
415
416
417
418
419
420
421
…
next ›
last »